A global research collaboration has revealed how certain gut cells switch on pain signals, which can linger long after the ...

There is good news for those with acute pain, as the FDA has approved a first-of-its-kind pain medication, and it’s one ...

While some fears are innate, others can be unlearned through experience, a process that has long intrigued neuroscientists. Now, researchers have identified a crucial brain pathway that helps suppress ...

A truly remarkable phenomenon had come into play – the effects of fear, stress and emotion on the brain had switched off their pain. But how does this work – and how can we use it to our ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

Please provide your email address to receive an email when new articles are posted on . An opioid-free protocol yielded noninferior pain scores vs. an opioid-containing protocol at 24 hours after ...

QIAGEN ingenuity pathway analysis (IPA), to identify the key signaling pathways, upstream regulators, and biological functions in these brain areas known to play a role in pain. Canonical pathway ...

Three studies at the University of Zurich demonstrate that hypnosis alters activity in the large-scale functional networks of ...

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare providers address pain management. Suzetrigine, also known as Journavx, is ...

scientists can predict which patients will develop chronic pain based on the extent of cross 'talk' between two regions of the brain, and ... Oct. 22, 2024 — In a study, researchers use ...

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...